Clinical Trial Update: Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

A completed clinical trial evaluating curcumin for cognitive dysfunction in schizophrenia (Phase 1/Phase 2) with published results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: VA Greater Los Angeles Healthcare System | Conditions: Schizophrenia, Cognition | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-15